These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 86831)

  • 21. Implication of decreased serum complement 3 in patients with diabetic nephropathy.
    Zhang J; Wang Y; Zhang R; Li H; Han Q; Guo R; Wang T; Li L; Liu F
    Acta Diabetol; 2018 Jan; 55(1):31-39. PubMed ID: 29043511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kidney function before pancreas transplant alone predicts subsequent risk of end-stage renal disease.
    Kim SJ; Smail N; Paraskevas S; Schiff J; Cantarovich M
    Transplantation; 2014 Mar; 97(6):675-80. PubMed ID: 24637866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Kidney function in diabetic patients with diabetes of a duration less than 15 years].
    Zimmermann K; Schneider H
    Z Urol Nephrol; 1985 Sep; 78(9):505-10. PubMed ID: 4072455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diabetic patient with renal insufficiency.
    Vanhille P
    Diabetes Metab; 2000 Jul; 26 Suppl 4():67-72. PubMed ID: 10922976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of intrarenal product TNF-alpha in the development of glomerular and tubulointerstitial tissues changes in elderly patients with diabetic nephropathy].
    Rakitianskaia IA; Riabov SI; Azanchevskaia SV; Riabova TS; Al-Barbari K; Gurkov AS; Popova VB
    Adv Gerontol; 2013; 26(4):658-65. PubMed ID: 24738256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does pregnancy alter the rate of progression of diabetic nephropathy?
    Reece EA; Winn HN; Hayslett JP; Coulehan J; Wan M; Hobbins JC
    Am J Perinatol; 1990 Apr; 7(2):193-7. PubMed ID: 2331283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Chronic Dialysis the Right Hard Renal End Point To Evaluate Renoprotective Drug Effects?
    Weldegiorgis M; de Zeeuw D; Dwyer JP; Mol P; Heerspink HJL
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1595-1600. PubMed ID: 28923834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prospective follow-up study of renal function in type 2 diabetes].
    Hadjadj S; Fanelli A; Torremocha F; Maréchaud R
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):928-32. PubMed ID: 11575233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial.
    Tan SMQ; Chiew Y; Ahmad B; Kadir KA
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30227659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical course of diabetic nephropathy.
    Kussman MJ; Goldstein H; Gleason RE
    JAMA; 1976 Oct; 236(16):1861-3. PubMed ID: 989537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Natural history of nephropathy in type I diabetes mellitus].
    Esmatjes E; Gutiérrez A; Goday A; Novials A; Ricart MJ; González MT; García M; Ríos M; Figuerola D
    Med Clin (Barc); 1988 Jan; 90(2):47-9. PubMed ID: 3347113
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathogenesis of diabetic nephropathy.
    van Dijk C; Berl T
    Rev Endocr Metab Disord; 2004 Aug; 5(3):237-48. PubMed ID: 15211095
    [No Abstract]   [Full Text] [Related]  

  • 33. Time trends in the epidemiology of renal transplant patients with type 1 diabetes mellitus over the last four decades.
    Cao C; Hellermann JP; Weber M; Ambühl PM
    Nephrol Dial Transplant; 2006 Mar; 21(3):770-5. PubMed ID: 16401627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic nephropathy: how effective is treatment in clinical practice?
    Joss N; Paterson KR; Deighan CJ; Simpson K; Boulton-Jones JM
    QJM; 2002 Jan; 95(1):41-9. PubMed ID: 11834772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy Trial.
    Evans M; Bain SC; Hogan S; Bilous RW;
    Nephrol Dial Transplant; 2012 Jun; 27(6):2255-63. PubMed ID: 22172728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved prognosis of diabetic nephropathy in type 1 diabetes.
    Andrésdóttir G; Jensen ML; Carstensen B; Parving HH; Hovind P; Hansen TW; Rossing P
    Kidney Int; 2015 Feb; 87(2):417-26. PubMed ID: 24918158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with the development of renal complications of diabetes mellitus in São Paulo city.
    Ferreira SR; Pinto FM
    Braz J Med Biol Res; 1997 Jun; 30(6):735-44. PubMed ID: 9292110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kidney transplantation in patients with type 1 diabetes mellitus: long-term prognosis for patients and grafts.
    Kim H; Cheigh JS
    Korean J Intern Med; 2001 Jun; 16(2):98-104. PubMed ID: 11590909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are glomerular lesions alternatives to microalbuminuria in predicting later progression of diabetic nephropathy?
    Shoji T; Kanda T; Nakamura H; Hayashi T; Okada N; Nakanishi I; Shimizu Y; Tsubakihara Y
    Clin Nephrol; 1996 Jun; 45(6):367-71. PubMed ID: 8793227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.